{
  "id": 17987450,
  "title": "Today: Rekordquartal für Apple, Ausblick enttäuscht | Evoniks gute Zahlen gegen Übernahme durch BASF",
  "url": "https://urgent.news/2026/11/03/today-rekordquartal-fur-apple-ausblick-enttauscht-evoniks-gute-zahlen",
  "topic": "business",
  "section": "Business",
  "published": "2026-11-03T16:15:29.000Z",
  "source": {
    "name": "Handelsblatt",
    "slug": "handelsblatt",
    "url": "https://www.handelsblatt.com/audio/today/today-apple-verbucht-rekordquartal-doch-der-ausblick-enttaeuscht-anleger/100267070.html"
  },
  "original_language": "de",
  "account": "Apple has achieved a record quarter, with revenue and profit exceeding expectations, but the outlook for the holiday period is less optimistic. In September's fourth quarter, Apple's revenue increased by 12% to $114.5 billion and earnings per share grew by 14% to $2.10. However, the growth outlook for the upcoming quarter is revised to a meager seven to ten percent, the weakest since over a year. The stock price dropped three percent after hours following the announcement. Thomas Jahn, co-leader of the Technology team at Handelsblatt, provides further insight into Apple's situation and future. Meanwhile, the Essen-based chemical company Evonik reported strong fourth-quarter results on Tuesday. The adjusted operating profit rose by 40% to €629 million, while revenue grew by 13% to €3.8 billion. Evonik's interim chief, Claus Rettig, emphasized the company's focus on its strategic direction and continued development as an independent entity during a conference call with analysts. The company's strong performance may be an attempt to deter a potential acquisition by its rival BASF. Evonik boosts operating profit and underscores independence.",
  "summary": "US-Tech-Gigant Apple und der Essener Chemiekonzern Evonik haben beide gute Quartalszahlen vorgelegt. Doch die allein reichen nicht: Während Apple die Anleger von der Zukunft überzeugen muss, kämpft Evonik um seine Eigenständigkeit.",
  "key_points": [
    "Apple reports record $114.5B revenue and 14% EPS growth in Q4",
    "Holiday outlook revised to weak 7-10% growth, stock down 3%",
    "Evonik's adjusted profit rises 40% to €629M, revenue up 13%"
  ],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}